115 related articles for article (PubMed ID: 26220604)
1. Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model.
Urueña C; Gomez A; Sandoval T; Hernandez J; Li S; Barreto A; Fiorentino S
Integr Cancer Ther; 2015 Sep; 14(5):468-83. PubMed ID: 26220604
[TBL] [Abstract][Full Text] [Related]
2. Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model.
Urueña C; Mancipe J; Hernandez J; Castañeda D; Pombo L; Gomez A; Asea A; Fiorentino S
BMC Complement Altern Med; 2013 Apr; 13():74. PubMed ID: 23552194
[TBL] [Abstract][Full Text] [Related]
3. An Immunomodulatory Gallotanin-Rich Fraction From
Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Romero P; Barreto A; Fiorentino S
Front Immunol; 2020; 11():584959. PubMed ID: 33312174
[TBL] [Abstract][Full Text] [Related]
4. Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin.
Sandoval TA; Urueña CP; Llano M; Gómez-Cadena A; Hernández JF; Sequeda LG; Loaiza AE; Barreto A; Li S; Fiorentino S
Am J Chin Med; 2016; 44(8):1693-1717. PubMed ID: 27852125
[TBL] [Abstract][Full Text] [Related]
5. Immune-system-dependent anti-tumor activity of a plant-derived polyphenol rich fraction in a melanoma mouse model.
Gomez-Cadena A; Urueña C; Prieto K; Martinez-Usatorre A; Donda A; Barreto A; Romero P; Fiorentino S
Cell Death Dis; 2016 Jun; 7(6):e2243. PubMed ID: 27253407
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of chemotherapy and P2Et extract combination in ex-vivo derived tumor mammospheres from breast cancer patients.
Urueña C; Sandoval TA; Lasso P; Tawil M; Barreto A; Torregrosa L; Fiorentino S
Sci Rep; 2020 Nov; 10(1):19639. PubMed ID: 33184339
[TBL] [Abstract][Full Text] [Related]
7. A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line.
Castañeda DM; Pombo LM; Urueña CP; Hernandez JF; Fiorentino S
BMC Complement Altern Med; 2012 Apr; 12():38. PubMed ID: 22490328
[TBL] [Abstract][Full Text] [Related]
8. The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells.
Prieto K; Lozano MP; Urueña C; Alméciga-Díaz CJ; Fiorentino S; Barreto A
Apoptosis; 2020 Dec; 25(11-12):875-888. PubMed ID: 33156457
[TBL] [Abstract][Full Text] [Related]
9. A Petiveria alliacea standardized fraction induces breast adenocarcinoma cell death by modulating glycolytic metabolism.
Hernández JF; Urueña CP; Cifuentes MC; Sandoval TA; Pombo LM; Castañeda D; Asea A; Fiorentino S
J Ethnopharmacol; 2014 May; 153(3):641-9. PubMed ID: 24637191
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from
Ballesteros-Ramírez R; Durán MI; Fiorentino S
Toxicol Rep; 2021; 8():258-263. PubMed ID: 33552924
[TBL] [Abstract][Full Text] [Related]
11. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
12. Eps8 vaccine exerts prophylactic antitumor effects in a murine model: a novel vaccine for breast carcinoma.
He YJ; Zhou J; Zhao TF; Hu LS; Gan JY; Deng L; Li Y
Mol Med Rep; 2013 Aug; 8(2):662-8. PubMed ID: 23754615
[TBL] [Abstract][Full Text] [Related]
13. Natural Products Induce Different Anti-Tumor Immune Responses in Murine Models of 4T1 Mammary Carcinoma and B16-F10 Melanoma.
Lasso P; Rojas L; Arévalo C; Urueña C; Murillo N; Fiorentino S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069022
[TBL] [Abstract][Full Text] [Related]
14. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells.
Guo W; Jia L; Xie L; Kiang JG; Wang Y; Sun F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S; Wang X
Cell Death Dis; 2024 Apr; 15(4):298. PubMed ID: 38678042
[TBL] [Abstract][Full Text] [Related]
15. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
16. Polyphenol-rich extract induces apoptosis with immunogenic markers in melanoma cells through the ER stress-associated kinase PERK.
Prieto K; Cao Y; Mohamed E; Trillo-Tinoco J; Sierra RA; Urueña C; Sandoval TA; Fiorentino S; Rodriguez PC; Barreto A
Cell Death Discov; 2019; 5():134. PubMed ID: 31531232
[TBL] [Abstract][Full Text] [Related]
17. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
Vendrell A; Gravisaco MJ; Pasetti MF; Croci M; Colombo L; Rodríguez C; Mongini C; Waldner CI
Vaccine; 2011 Jan; 29(4):728-36. PubMed ID: 21095252
[TBL] [Abstract][Full Text] [Related]
18. Brazilein, an important immunosuppressive component from Caesalpinia sappan L.
Ye M; Xie WD; Lei F; Meng Z; Zhao YN; Su H; Du LJ
Int Immunopharmacol; 2006 Mar; 6(3):426-32. PubMed ID: 16428078
[TBL] [Abstract][Full Text] [Related]
19. Identification of a highly immunogenic mouse breast cancer sub cell line, 4T1-S.
Abe H; Wada H; Baghdadi M; Nakanishi S; Usui Y; Tsuchikawa T; Shichinohe T; Hirano S; Seino K
Hum Cell; 2016 Apr; 29(2):58-66. PubMed ID: 26857856
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]